Alexander Joseph Ambinder

机构：Johns Hopkins University, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0003-0855-9653

发表论文 99 篇 · 总被引 801 次 · h-index 14

代表论文

• A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study (2023 · Blood · 被引 13)
• Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide (2024 · Bone Marrow Transplantation · 被引 12)
• Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide (2024 · Transplantation and Cellular Therapy · 被引 10)
• Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI (2026 · Blood Advances · 被引 6)
• Ivosidenib or venetoclax combined with hypomethylating agents in IDH1-mutated acute myeloid leukemia: a real-world study (2025 · Blood Neoplasia · 被引 5)
• A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress) (2024 · Blood · 被引 5)